ONDANSETRON HYDROCHLORIDE
Generic: ONDANSETRON HYDROCHLORIDE, ONDANSETRON
Aurobindo Pharma LimitedManufacturer
ORALRoute
ONDANSETRON HYDROCHLORIDEActive Substance
2007-07-31Original Approval
ONDANSETRON HYDROCHLORIDE is FDA application ANDA078539, sponsored by AUROBINDO PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2022-04-13
Ondansetron HCL, Tab 8 mg filmcoated, 30-count bottle, Rx only, MFG: Sandoz Pharma, NDC 65862-188-30cGMP deviations: Temperature abuse
Class II2023-11-14
Ondansetron Injection, USP, 4 mg/2 mL (2 mg/mL), 2 mL per vial, Rx only, Manufactured for: Baxter Healthcare CorporationFailed pH Specifications
Top Reported Reactions
1
NAUSEA
2,531 reports
2
FATIGUE
1,603 reports
3
OFF LABEL USE
1,418 reports
4
HEADACHE
1,394 reports
5
DIARRHOEA
1,356 reports
6
VOMITING
1,238 reports
7
PAIN
1,134 reports
8
DYSPNOEA
1,089 reports
9
DRUG INEFFECTIVE
986 reports
10
PYREXIA
806 reports